Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  GlobalData Plc    DATA   GB00B87ZTG26

GLOBALDATA PLC

(DATA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

GlobalData : Coronavirus outbreak derails IPOs

share with twitter share with LinkedIn share with facebook
share via e-mail
03/23/2020 | 07:50am EDT
23 Mar 2020
Coronavirus outbreak derails IPOs
Posted in Business Fundamentals

With the spread of coronavirus (COVID-19) to several countries and the World Health Organization (WHO) declaring it as a pandemic, the ripple effects can also be felt in financial markets with many companies putting their planned initial public offerings (IPO) on hold, according to GlobalData, a leading data and analytics company.

In May 2019, oil and gas company Wintershall DEA shared its plans to issue shares in an IPO ready for listing by the end of 2019. The company then expected to float its shares in 2020. However, on March 9, 2020, the company announced that the IPO may be delayed due to coronavirus outbreak and the ongoing oil price war between Saudi Arabia and Russia.

Similarly, chemical company Rossari Biotech filed a draft prospectus with the Securities and Exchange Board of India (SEBI) in December 2019 for an IPO. However, on March 12, 2020, the company announced a postponement of its IPO citing turmoil in equity markets due to COVID-19.

Aurojyoti Bose, Lead Analyst at GlobalData, comments: 'Fear of a dampened stock market debut, on the back of unfavorable market conditions due to the coronavirus outbreak and concerns related to not getting a good response from investors, could be the trigger for management preferring to wait until market conditions improve. Nevertheless, some companies also see opportunities amid the coronavirus pandemic.

'For instance, Chinese firm Sansure Biotech (Sansure) applied for an IPO on March 5, 2020. Sansure is among the six firms approved to sell coronavirus test kits in China and has already produced four million kits as of February 29, 2020. The company aims to raise ¥557m (US$80m) through the IPO.'

Disclaimer

GlobalData plc published this content on 23 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 March 2020 12:49:02 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on GLOBALDATA PLC
08:43aGLOBALDATA : Global gas flaring value approaches US$24bn a year if priced at Eur..
PU
08:23aGLOBALDATA : New incentives and benefits can boost R&D ecosystem for new drug de..
PU
03/27GLOBALDATA : Novartis' Zolgensma expected to generate global sales of $2.5bn by ..
PU
03/26GLOBALDATA : Goodyear's sentiments slide in Q4 2019 due to challenging environme..
PU
03/26GLOBALDATA : Permian production already a victim of oil price war
PU
03/26GLOBALDATA : Sparkling wine emerged as most mentioned wine category among indust..
PU
03/26GLOBALDATA PLC : Ex-dividend day for final dividend
FA
03/25GLOBALDATA : Amid Covid-19 outbreak GlobalData suggests short-term and long-term..
PU
03/24GLOBALDATA : Telecom equipment companies must minimize risks to the supply chain..
AQ
03/23GLOBALDATA : Coronavirus outbreak derails IPOs
PU
More news
Financials (GBP)
Sales 2020 186 M
EBIT 2020 48,8 M
Net income 2020 23,0 M
Debt 2020 35,1 M
Yield 2020 1,58%
P/E ratio 2020 59,7x
P/E ratio 2021 45,0x
EV / Sales2020 6,99x
EV / Sales2021 6,54x
Capitalization 1 268 M
Chart GLOBALDATA PLC
Duration : Period :
GlobalData Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLOBALDATA PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 1 200,00  GBp
Last Close Price 1 075,00  GBp
Spread / Highest target 11,6%
Spread / Average Target 11,6%
Spread / Lowest Target 11,6%
EPS Revisions
Managers
NameTitle
Michael Thomas Danson Chief Executive Officer & Director
Bernard Anthony Cragg Chairman
Sally Kate Miranda Johnson Chief Financial Officer
Peter Martin Harkness Independent Non-Executive Director
Murray Legg Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GLOBALDATA PLC-16.67%1 574
S&P GLOBAL INC.-12.20%57 707
RELX PLC-11.13%40 475
THOMSON REUTERS CORPORATION-6.28%30 623
WOLTERS KLUWER-8.31%17 577
EQUIFAX INC.-14.68%14 582